Confo Therapeutics Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody® Drug Discovery and Development Technology in Rare Diseases

GHENT, Belgium–(BUSINESS WIRE)–Confo Therapeutics announced today that it has been awarded a EUR 1.7 million grant from Flanders Innovation & Entrepreneurship (VLAIO). The award further validates and supports Confo’s leadership in the discovery of novel GPCR (G protein-coupled receptor) drug candidates using its proprietary universal ConfoBody® technology, specifically for the purpose of developing needed new … [Read more…]

Turkish Medical Team Separates Conjoined Twins in 9 Hours, Breaking World Record

The team led by Prof. Karaaltin, employed revolutionary techniques to save lives of conjoined twins ISTANBUL–(BUSINESS WIRE)–A Turkish medical team has successfully separated conjoined twins shortly after birth by employing a range of innovative techniques, including virtual simulations and 3D modeling. Carried out at Istanbul’s Acibadem Hospital, the successful procedure set a new world record … [Read more…]

Iktos Announces Collaboration With Galapagos in AI For Drug Design

PARIS–(BUSINESS WIRE)–Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a collaboration with Galapagos, a leading global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines, to apply Iktos’s generative modelling artificial intelligence (AI) technology in one of Galapagos drug discovery programs. Under the agreement, Iktos will apply … [Read more…]

Transgene and BioInvent Announce Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BT-001 in Combination with KEYTRUDA®

STRASBOURG, France & LUND, Sweden–(BUSINESS WIRE)–#HBV–Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immuno-modulatory antibodies for cancer immunotherapy, today announced a clinical trial collaboration and … [Read more…]

Owens & Minor Breaks Ground on Center of Excellence for Medical Supply Logistics in West Virginia

Center slated to open in late 2023; will serve as a state-of-the-art hub for managing and coordinating complex medical supply logistics for WVU Medicine Groundbreaking advances the long-term strategic collaboration between WVU Medicine and Owens & Minor to help strengthen healthcare resiliency and preparation in West Virginia and beyond RICHMOND, Va.–(BUSINESS WIRE)–Owens & Minor, Inc. … [Read more…]

Greenbrook TMS Provides an Update on the Success TMS Acquisition

TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, announced today an update on the status of its previously-announced proposed acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). … [Read more…]

Gilead Resubmits New Drug Application to U.S. Food and Drug Administration for Lenacapavir, an Investigational, Long-Acting HIV-1 Capsid Inhibitor

– NDA Resubmission Addresses Issues Related to Vial Compatibility – – If Approved, Lenacapavir Would be the First and the Only HIV-1 Treatment Option Administered Twice-Yearly – FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the resubmission of the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lenacapavir, … [Read more…]

Vagaro and Thrivo Host Pride Party at First-Ever Metaverse Salon

DUBLIN, Calif.–(BUSINESS WIRE)–Vagaro and Thrivo recently announced they will co-host a free Pride celebration at the first-ever Metaverse salon on June 30th to officially close out Pride Month. The virtual dance party will take place on the rooftop of the Thrivo Salon, located in the Fashion District of Decentraland, at 4pm PT/7pm ET. Virtual partygoers … [Read more…]

Kezar Life Sciences Announces Positive Topline Results from the MISSION Phase 2 Trial Evaluating Zetomipzomib for the Treatment of Patients with Lupus Nephritis

11 of 17 patients (64.7%) achieved an overall renal response of 50% or greater reduction in urine protein to creatinine ratio (UPCR) at 6 months 6 of 17 patients (35.2%) achieved a complete renal response, including a UPCR of 0.5 or less at 6 months Zetomipzomib continues to demonstrate a favorable safety and tolerability profile … [Read more…]

Bubbles Bring Miracles to Sick Ukrainian Children

L’VIV, Ukraine–(BUSINESS WIRE)–#BubbleMtg2021–Miracles have been few and far between for Ukrainian children who are fleeing war zones while facing cancer and other life threatening diseases. But tiny ultrasound microbubbles are now saving young lives and bringing hope to children like Nastya, a 15 year old girl from a small village near Kiev, who was evacuated … [Read more…]